Rebrain services provide precise brain targeting for DBS neurosurgery, enhancing patient outcomes in Parkinson’s disease and Essential Tremor treatments

We are pleased to announce that La Gazette du Laboratoire has featured RebrAIn for our revolutionary advancements in neurosurgical targeting for Deep Brain Stimulation (DBS).

The article highlights our collaboration with SATT Aquitaine Science Transfert and the development of our supervised AI-driven platform, OptimDBS, designed to enhance the precision and effectiveness of DBS treatments.

Learn more about how RebrAIn is transforming neurosurgery and improving patient outcomes by reading the full article here, in french.

An English translation by Google is available here.